Doctor profile · Federal record
Dr. BINDU AKKANTI, M.D
Critical Care Medicine (Internal Medicine) Physician (CMS: CRITICAL CARE (INTENSIVISTS)) · Internal Medicine Physician · Internal Medicine Physician · Pulmonary Disease Physician · HOUSTON, TX
- NPI 1982663514
- Accepts Medicare
- MIPS 81.3 / 100 · 2023
- 22 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6411 FANNIN ST
HOUSTON, TX 770301501
(713) 704-4000 - Mailing address
-
6431 FANNIN ST # 1.268
HOUSTON, TX 770301501
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- June 29, 2022
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207RC0200X — NUCC code
- State licenses (2)
- Texas #M7005 · Massachusetts #226120
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1982663514. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
455
Distinct HCPCS
10
Medicare allowed
$52,440
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99291 |
Critical care, first 30-74 minutes | 125 | 44 | $220 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 105 | 48 | $122 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 49 | 34 | $100 | |
94618 |
Test for exercise-induced lung stress | 39 | 33 | $22 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 30 | 28 | $68 | |
94010 |
Test to measure expiratory airflow and volume | 29 | 26 | $8 | |
94726 |
Test to determine lung volumes using sensors | 23 | 21 | $12 | |
94729 |
Test to examine how well the lungs exchange gases | 23 | 21 | $9 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 20 | 13 | $81 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 12 | 11 | $167 |
In context: peer comparison
Among 46 peers in this city , average services per provider: 83. This provider delivers 5.5× the peer median.Open Payments
Industry payments received
All-time total
$64,520
Transactions
51
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABIOMED | 20 | $40,049.06 | |
| Actelion Pharmaceuticals US, Inc. | 22 | $23,918.52 | |
| Abbott Laboratories | 1 | $153.33 | |
| Inari Medical, Inc. | 1 | $131.78 | |
| AstraZeneca Pharmaceuticals LP | 1 | $117.72 | |
| United Therapeutics Corporation | 1 | $33.86 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.41 | |
| GlaxoSmithKline, LLC. | 1 | $25.82 | |
| Insmed, Inc. | 1 | $22.14 | |
| Novo Nordisk Inc | 1 | $21.21 | |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18.50 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
489
Patients
31
Total drug cost
$2,827,469
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Opsumit (Macitentan) | Brand | 86 | 13 | $1,140,559 |
| Sildenafil Citrate | Generic | 76 | 18 | $8,091 |
| Ambrisentan | Generic | 73 | 0 | $280,799 |
| Remodulin (Treprostinil Sodium) | Brand | 41 | 0 | $132,470 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 32 | 0 | $821 |
| Uptravi (Selexipag) | Brand | 31 | 0 | $708,295 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 26 | 0 | $20,301 |
| Spiriva Handihaler (Tiotropium Bromide) | Brand | 19 | 0 | $11,871 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 18 | 0 | $16,409 |
| Tyvaso Dpi (Treprostinil) | Brand | 16 | 0 | $377,199 |